Diamond
-
Alcon
Alcon
Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care.
Being a truly global company, we work in 60 countries and serve patients in more than 140 countries. We have a long history of industry firsts, and each year we commit a substantial amount in Research and Development to meet customer needs and patient demands.
Platinum
-
Geuder
Geuder
Geuder is one of the world’s leading manufacturers of innovative ophthalmic surgical instruments and device systems as well as high-purity ophthalmic fluids. In our ongoing effort to provide you with the best possible service, we are expanding our production and service areas. These expansions, along with the associated relocation and the commissioning of the new facilities, will enable us to significantly increase our capacities and the quality of our services. We are confident that these changes will allow us to better meet your expectations and further strengthen our collaboration.
Gold
-
AbbVie
AbbVie
Your Vision. Our Mission.
At AbbVie, we set our sights on a future where vision lasts a lifetime. With a legacy of more than 75 years in eye care, we are focused on preserving and protecting vision for patients around the world. We treat conditions from the front to the back of the eye, including glaucoma, ocular surface disease, and retinal diseases.
-
Bausch + Lomb
Bausch + Lomb
Bausch + Lomb is a leading global eye care company celebrating over 170 years of expertise in ophthalmology. Our Surgical Division provides a comprehensive portfolio for anterior, posterior, premium and glaucoma surgery. The SeeLuma™ Fully Digital Surgical Visualization Platform is amongst our latest innovations, along with our next generation ELIOS™ technology for glaucoma surgery. The Stellaris Elite™ vision enhancement system, and the latest additions to our premium IOL portfolio, the LuxLife® and enVista Aspire™ IOLs, plus the TENEO™ 317 M2 Excimer Laser also feature in our range.
Learn more at our Bausch + Lomb Satellite Lunchtime Symposium on 13th September at 1pm in Auditorium 10 and visit us at booth C2.025.
-
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG
As one of the world’s leading medical technology companies, ZEISS Medical Technology is a visionary company at the forefront of healthcare’s digital transformation. ZEISS helps doctors all over the world improve their patients’ lives. With a special focus on ophthalmology, ophthalmic surgery and advanced visualization systems in the field of microsurgery, ZEISS supports healthcare professionals in setting new standards of more personalized, data-driven care with connected workflow solutions and proven diagnostic and treatment technologies based on a long history of cutting-edge innovation.
-
Johnson&Johnson Vision
Johnson&Johnson Vision
Johnson & Johnson Vision (JJV) is a subsidiary of Johnson & Johnson and is composed of two divisions, Johnson & Johnson Surgical Vision and Johnson & Johnson Vision Care (Contact Lens).
Services include Intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastic, Microkeratomes and related products used in cataract and refractive surgery.
Johnson and Johnson Surgical Vision is based in Santa Ana, California, and Johnson & Johnson Vision Care is based in Jacksonville, Florida. JJV employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries.
In February 2017, Abbott Medical Optics changed its name to Johnson & Johnson Vision following its $4.3 billion acquisition by Johnson & Johnson.
-
STAAR Surgical AG
STAAR Surgical AG
STAAR designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. To learn more visit www.discovericl.com
Silver
-
GLAUKOS
GLAUKOS
Glaukos is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal disease.
Our mission is to truly transform vision by pioneering novel, dropless platforms that can meaningfully advance the standard of care and improve outcomes for patients suffering from sight-threatening chronic eye diseases.
-
Heidelberg Engineering
Heidelberg Engineering
Heidelberg Engineering pioneers imaging and data technologies to optimize ophthalmic solutions that empower eye care professionals who want to improve the holistic health of patients. Since 1990, uncompromising quality and education play a large part in fostering the diagnostic confidence that has become synonymous with the global brand.
The SPECTRALIS multi-modal imaging platform for the posterior segment offers unparalleled retinal image quality and reproducibility, supporting the diagnosis and treatment of glaucoma, AMD, diabetic retinopathy and many other retinal diseases. The
ANTERION multi-disciplinary imaging platform is an easy-to-use, all-in-one anterior segment solution, with all measurements based solely on high-quality OCT technology.
The HEYEX 2 image management and device integration platform manages all diagnostic images and supports workflow efficiency with standardized data and interfaces.
-
Rayner
Rayner
Since the implantation of the first Rayner intraocular lens by Sir Harold Ridley in 1949, Rayner has had the goal to improve vision and restore sight worldwide. Today, Rayner’s mission remains to deliver innovative and clinically superior ophthalmic products that respond to the expectations of our global customers to improve the sight and quality of life of their patients.Headquartered in Worthing, United Kingdom, Rayner markets its medical devices, pharmaceuticals, and digital solutions worldwide in over 80 countries through a network of distributors and includes direct sales teams in the United Kingdom, Eire, USA, Canada, Brazil, India, Poland, Australia, Germany, Austria, Switzerland, France, Italy, Spain, and Portugal. -
SCHWIND eye-tech-solutions
SCHWIND eye-tech-solutions
SCHWIND eye-tech-solutions is a refractive technology pioneer, delivering advanced vision correction solutions and fostering strong customer partnerships.
The SCHWIND AMARIS excimer and ATOS femtosecond lasers offer an exceptional range of applications—from PRK, TransPRK (SmartSurfACE), LASEK, FemtoLASIK, PTK, TransPTK, CXL, and PresbyMAX with the AMARIS series, to LASIK flap creation and lenticule extraction (SmartSight NOVA) with the ATOS. Combined with SCHWIND diagnostic devices, these systems provide versatile therapeutic options that clearly set SCHWIND technology apart.
-
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals applies proven science and new technology to revolutionize treatment for patients, starting with eye care.
Tarsus is advancing the development and commercialization of therapeutic candidates to address highly prevalent diseases with limited treatment options across a range of categories including eye care and infectious disease prevention. TP-03, is FDA-approved in the United States for the treatment of Demodex blepharitis and is on-track for potential European regulatory approval in 2027 of a preservative-free formulation. Tarsus is also developing TP-04 and TP-05 for treatment of Ocular Rosacea and Lyme disease.
-
VSY Biotechnology
VSY Biotechnology
VSY Biotechnology Gmbh is a progressive and innovative company that focuses on consumer satisfaction by creating superior state-of-the-art ophthalmology and orthopedics products designed and manufactured to greatly enhance and improve vision and comfort for a wide range of patients around the globe.
Product portfolio includes intraocular lenses to treat cataract and refractive errors like presbyopia, astigmatism and ocular problems, as well as injector and cartridge systems , viscoelastics for ophthalmology and orthopedics and hyaluronic acid (HA) viscosupplement products for orthopedics.
Starting from foundation to today, quality and safety standards are the source of our success. We are serving over 90+ countries around the globe from our headquarters with a professional marketing and distribution approach.
With our know-how in biotechnology, we will continue to enlighten the world by combining these disciplines for the patients.
The company is owned by Evmann Investments Holding BV at 100%. Evmann Investments Holding BV is a Dutch resident Holding company which currently has investments in ophthalmology and orthopedics industries. Its strategy is to make investments especially in areas creating value for a healthier life under its motto of “Invest for Life”.
